Skip to main content
MACROGENICS INC logo

MACROGENICS INC — Investor Relations & Filings

Ticker · MGNX ISIN · US5560991094 LEI · 5493001KJQUA83L8MH79 US Manufacturing
Open in API
Filings indexed 894 across all filing types
Latest filing 2013-09-04 Capital/Financing Update
Country US United States of America
Listing US MGNX

About MACROGENICS INC

https://www.macrogenics.com/

MacroGenics, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative antibody-based therapeutics for the treatment of cancer. The company utilizes its proprietary antibody engineering platforms, including the DART (Dual-Affinity Re-Targeting) and TRIDENT technologies, to create novel product candidates. Its pipeline consists of investigational treatments such as monoclonal antibodies, antibody-drug conjugates (ADCs), and multi-specific antibodies. MacroGenics maintains fully-integrated capabilities, from research and discovery through to GMP (Good Manufacturing Practice) manufacturing, to advance its portfolio of potential medicines for patients with unmet medical needs.

Recent filings

Filing Released Lang Actions
FORM S-1
Capital/Financing Update Classification · 100% confidence The document is a Form S-1 Registration Statement filed with the SEC, which is used for initial public offerings (IPOs) to register securities for sale to the public. It includes detailed information about the company, its business, financial data, risk factors, management, and the offering itself. This type of filing is distinct from annual reports, earnings releases, or other financial reports. It is a capital markets filing related to the company's fundraising and securities registration. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it is not merely an announcement but the actual registration statement text.
2013-09-04 English
Regulatory Filings 2013
Regulatory Filings
2013-08-28 English
Capital/Financing Update 2013
Capital/Financing Update Classification · 100% confidence The document is a Form S-1 Registration Statement filed with the U.S. Securities and Exchange Commission (SEC) by MacroGenics, Inc. It is a registration statement under the Securities Act of 1933, used for initial public offerings (IPOs) or other securities offerings. The text includes detailed information about the company, its business, management, risk factors, use of proceeds, and other disclosures typical of an S-1 filing. This is not an annual report, earnings release, or any other type of financial report but a registration statement for a securities offering. According to the filing definitions, this corresponds to a Capital/Financing Update (CAP) as it relates to company fundraising and capital structure changes through a public offering.
2013-08-02 English
Regulatory Filings 2011
Regulatory Filings
2011-01-31 English
AUTO-GENERATED PAPER DOCUMENT
Regulatory Filings
2008-10-23 English
AUTO-GENERATED PAPER DOCUMENT
Regulatory Filings
2008-07-31 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.